Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Minority Interest: 2020-2024

Historic Minority Interest for ImmunityBio (IBRX) over the last 5 years, with Dec 2024 value amounting to $969,000.

  • ImmunityBio's Minority Interest fell 7.81% to $909,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $909,000, marking a year-over-year decrease of 7.81%. This contributed to the annual value of $969,000 for FY2024, which is 7.71% down from last year.
  • Per ImmunityBio's latest filing, its Minority Interest stood at $969,000 for FY2024, which was down 7.71% from $1.1 million recorded in FY2023.
  • Over the past 5 years, ImmunityBio's Minority Interest peaked at $1.3 million during FY2020, and registered a low of -$2.5 million during FY2022.
  • In the last 3 years, ImmunityBio's Minority Interest had a median value of $969,000 in 2024 and averaged -$158,000.
  • Its Minority Interest has fluctuated over the past 5 years, first tumbled by 232.02% in 2021, then soared by 142.12% in 2023.
  • Over the past 5 years, ImmunityBio's Minority Interest (Yearly) stood at $1.3 million in 2020, then slumped by 232.02% to -$1.7 million in 2021, then plummeted by 43.28% to -$2.5 million in 2022, then surged by 142.12% to $1.1 million in 2023, then decreased by 7.71% to $969,000 in 2024.